Astex Pharmaceuticals Inc.  – NasdaqGS: ASTX

This is one of my favorites, and it has a big move in the past week.  The recent sharp move upwards does lead one to holding back on jumping in here necessarily. This becomes one to grab on a pull-back only.  However, let’s look at why this one is so strong. I am not going to put all of the latest headlines in, nor am I going to throw in a bunch of quotes from the latest 10-Q.

First the risks with ASTX: “Since inception, we have funded our research and development activities primarily from private placements and public offerings of our securities, milestone and other payments from collaborators, sales of our products, and royalty revenue on sales of Dacogen. As a result of our substantial research and development expenditures and minimal product revenues, we have incurred cumulative losses of $330.2 million through June 30, 2013, and have not consistently generated…

SEE ASTX IN STOCKGURU’S 12 BIOTECH BREAKOUT STOCKS

SEE THE ENTIRE LIST OF STOCKGURU’S 12 BIOTECH BREAKOUT STOCKS